Table of Contents
Frequently Asked Questions
What is activity code 7020.89 and what does it permit in Dubai
Activity code 7020.89 — Pharmaceutical Consultancies falls under ISIC Division 70 (Management Consultancy Activities) and is specifically applied to pharmaceutical and life sciences advisory services. It is a professional services licence, meaning it covers purely advisory work rather than trading, manufacturing, or clinical operations.
Permitted services include regulatory strategy and submissions support, drug registration advisory, GMP compliance consulting, pharmacovigilance advisory, and market access consulting across GCC jurisdictions. The licence does not permit wholesale distribution, retail dispensing, or manufacturing of any kind.
Who are the typical clients of a pharmaceutical consultancy in Dubai
A pharmaceutical consultancy licensed under activity code 7020.89 can serve a broad range of clients across the healthcare and life sciences ecosystem. Typical clients include pharmaceutical manufacturers, biotech firms, hospital procurement teams, importers, and government health bodies.
Given Dubai's position as a regional hub, many consultancies also serve clients based elsewhere in the GCC who need guidance on UAE regulatory requirements, drug registration processes, or market entry strategy. This regional demand is a key driver of growth in the sector.
What is the difference between setting up on the Dubai mainland versus a free zone for this licence
A Dubai mainland licence issued by the Department of Economy and Tourism (DET) gives direct access to federal government contracts and the full UAE client base. However, depending on the legal structure chosen, it may require a local service agent or an Emirati partner, and setup typically takes two to four weeks with additional regulatory touchpoints.
A free zone licence, such as one through Meydan Free Zone, offers 100% foreign ownership, no paid-up capital requirement, and a significantly faster setup process of three to seven working days. Remote incorporation is available, and virtual office options keep overhead low — making it well suited to lean consultancy operations targeting regional or international clients.
Can a foreign national own 100% of a pharmaceutical consultancy in Dubai
Yes. 100% foreign ownership is available for pharmaceutical consultancy businesses established through Meydan Free Zone. This removes the need for an Emirati partner or local sponsor, which is a significant advantage for international professionals entering the Dubai market.
On the mainland, the ownership structure depends on the legal form chosen, and some setups may still require a local service agent. For most foreign consultants, the free zone route offers the cleaner and more straightforward ownership arrangement.
What documents are needed to apply for a pharmaceutical consultancy licence in Dubai
For most free zone applications, the documentation requirements are straightforward. Standard requirements include a passport copy, visa page, Emirates ID (if you are a UAE resident), and a brief business plan summary outlining your intended advisory services.
Importantly, no notarised documents are required for most free zone applications, and the process can be completed remotely — meaning you do not need to be physically present in the UAE to incorporate your business. This makes the setup process accessible to consultants based internationally.
Which regulators are relevant to pharmaceutical consultancy operations in Dubai
The two primary regulatory bodies are the Dubai Health Authority (DHA), which governs healthcare activities at the emirate level, and the Ministry of Health and Prevention (MOHAP), which serves as the federal authority responsible for drug registration across the UAE. Both are relevant depending on the nature of advisory work being undertaken.
If your consultancy's services extend to clinical trial management or direct drug registration submissions on behalf of clients, it is advisable to coordinate with both MOHAP and DHA early in the setup process to determine whether additional approvals or registrations are required beyond the standard business licence.
How long does it take to get a pharmaceutical consultancy licence in Dubai
The timeline depends on the jurisdiction chosen. Through Meydan Free Zone, licences are typically issued within three to seven working days, making it one of the faster routes to establishing a pharmaceutical consultancy in Dubai. Remote incorporation means the process can begin without travelling to the UAE.
A mainland (DET) licence generally takes longer — typically two to four weeks — due to additional regulatory touchpoints and the involvement of the Department of Economy and Tourism. For consultants prioritising speed to market, the free zone route offers a clear advantage.
How large is the UAE pharmaceutical market and why is consultancy demand growing
The UAE pharmaceutical market is projected to exceed USD 6 billion by 2028, reflecting strong and sustained growth driven by population expansion, increased healthcare investment, and the UAE's ambitions as a regional medical hub. This scale creates significant demand for specialist advisory services across regulatory, compliance, and market access functions.
Pharmaceutical manufacturers and biotech firms entering the GCC frequently require expert guidance on drug registration, GMP compliance, and pharmacovigilance — areas where a licensed consultancy can add direct value. The combination of market growth and regulatory complexity makes Dubai a strategically attractive base for pharmaceutical consultancy operations.
Pharmaceutical Consultancy License in Dubai
Dubai's pharmaceutical sector is expanding rapidly, and consultancy firms advising on regulatory compliance, drug registration, and market entry are in high demand across the GCC. Activity code 7020.89 — Pharmaceutical Consultancies — offers a clean, focused licence structure for professionals operating in this space. This guide covers what the licence permits, who it suits, and the practical steps to establish one in Dubai.
What a Pharmaceutical Consultancy Licence Covers
Activity code 7020.89 sits within ISIC Division 70 — Management Consultancy Activities — applied specifically to pharmaceutical and life sciences advisory. It is a professional services licence, not a trading or manufacturing one.
Permitted services under this activity include:
- Regulatory strategy and submissions support
- Drug registration advisory (coordinating with MOHAP and DHA)
- GMP (Good Manufacturing Practice) compliance consulting
- Pharmacovigilance advisory services
- Market access and market entry consulting across GCC jurisdictions
This licence does not permit manufacturing, wholesale distribution, retail dispensing, or clinical operations. The scope is purely advisory. Typical clients include pharmaceutical manufacturers, biotech firms, hospital procurement teams, importers, and government health bodies.
Business Activities List
Explore Over 2,500+Key Stats at a Glance
| Metric | Detail |
|---|---|
| UAE pharmaceutical market size (projected 2028) | USD 6 billion+ (mohap.gov.ae) |
| Primary regulator in Dubai | Dubai Health Authority (dha.gov.ae) |
| Federal drug registration authority | MOHAP (mohap.gov.ae) |
| Foreign ownership | 100% via Meydan Free Zone |
| Licence turnaround | 3–7 working days (Meydan Free Zone) |
| Activity code | 7020.89 — Pharmaceutical Consultancies |
Free Business Setup Cost Calculator
Calculate NowMainland vs Free Zone: Choosing the Right Structure
The two primary options are a Dubai mainland licence issued by the Department of Economy and Tourism (DET, formerly DED), or a free zone licence through an authority such as Meydan Free Zone.
Mainland (DET)
Provides direct access to federal government contracts and the full UAE client base. Depending on the legal structure, some mainland setups may require a local service agent or an Emirati partner. Setup typically takes two to four weeks and involves additional regulatory touchpoints.
Meydan Free Zone
Offers 100% foreign ownership, no paid-up capital requirement, and a significantly faster setup process. Remote incorporation is available — you do not need to be in the UAE to complete the process. Virtual office and flexible desk options keep overhead low, which suits lean consultancy operations. Free zone entities can serve UAE-based clients through a properly structured service agreement or via a local distributor arrangement where required.
For most pharmaceutical consultants targeting regional or international clients, Meydan Free Zone is the more practical starting point.
Start Your UAE Company Remotely
Get in Touch NowStep-by-Step Licence Setup Guide
Step 1: Confirm Your Business Activity
Select activity code 7020.89 — Pharmaceutical Consultancies. Verify that your intended scope is purely advisory. If your services extend to clinical trial management or direct drug registration submissions on behalf of clients, coordinate early with MOHAP and DHA regarding any additional approvals required.
Step 2: Choose Your Jurisdiction
Meydan Free Zone for speed, ownership simplicity, and low overhead. DET mainland if you require direct access to government tenders or a broader local market presence from day one.
Step 3: Reserve Your Trade Name
Check name availability and confirm compliance with UAE naming conventions — no references to governments, religious terms, or restricted words.
Step 4: Submit Incorporation Documents
Standard requirements include a passport copy, visa page, Emirates ID (if UAE-resident), and a brief business plan summary. No notarised documents are required for most free zone applications.
Step 5: Receive Your Licence
Meydan Free Zone typically issues within three to seven working days. DET mainland applications generally take two to four weeks depending on activity approvals.
Step 6: Open a Corporate Bank Account
Select a UAE bank with experience in professional services or life sciences clients. Have your licence, incorporation documents, and business plan ready — banks conduct their own due diligence.
Step 7: Apply for Investor or Partner Visa
If you intend to reside in the UAE, apply for your residency visa linked to the free zone or mainland entity. Additional visa allocations are available based on office space tier.
Costs, Visas, and Ongoing Compliance
Meydan Free Zone licences for this activity start from approximately AED 12,500 per year, inclusive of one visa allocation. Additional visa quotas are available by upgrading your office package.
Key ongoing obligations to plan for:
- Annual licence renewal: Required each year; straightforward for free zone entities with no structural changes
- Audit requirements: Free zone consultancies below certain thresholds are not mandated to submit audited accounts, though this may change as CT compliance matures
- Corporate tax: The UAE introduced a 9% corporate tax from June 2023. Qualifying free zone persons may benefit from the 0% rate on qualifying income — confirm your eligibility with a tax adviser. Refer to the Federal Tax Authority (tax.gov.ae) for current guidance
- Bookkeeping: Maintain clean financial records from the outset. CT compliance requires it, and banks will expect it
Conclusion
A Pharmaceutical Consultancy licence under activity code 7020.89 is a straightforward, low-overhead structure for advisors serving the GCC's growing life sciences sector. The scope is well-defined, the regulatory burden is manageable for a purely advisory operation, and free zone setup through Meydan offers full foreign ownership with a fast, remote-friendly process.
If you are advising pharmaceutical manufacturers, biotech firms, or health authorities on regulatory compliance, drug registration, or market access — this is the correct licence category, and Dubai is the right base.
Speak to the Meydan Free Zone team to confirm your activity scope, get a cost breakdown, and start your application.
